![Theodora Caroline Harold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Theodora Caroline Harold
Plus aucun poste en cours
Profil
Theodora Caroline Harold is currently Chief Executive Officer & Director at T-Therapeutics Ltd. since 2025.
Former roles include Chief Executive Officer at Crescendo Biologics Ltd. from 2019 to 2025, Independent Non-Executive Director at Synairgen Plc from 2021 to 2022, Secretary, Board Member & Finance Director at Akamis Bio Ltd. from 2012 to 2013, Secretary & Finance Director at MISSION Therapeutics Ltd., Non-Executive Director at Chronos Therapeutics Ltd., and Principal at PricewaterhouseCoopers LLP, RioTech Pharmaceuticals Ltd., Cytomyx Holdings Plc, OrthoMimetics Ltd., and Hybrid BioSystems Ltd.
Postes actifs de Theodora Caroline Harold
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Theodora Caroline Harold
| Sociétés | Poste | Fin |
|---|---|---|
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Directeur Général | 01/03/2025 |
| SYNAIRGEN PLC | Directeur/Membre du Conseil | 29/09/2022 |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Directeur/Membre du Conseil | - |
OrthoMimetics Ltd.
 OrthoMimetics Ltd. Medical SpecialtiesHealth Technology Designs, develops and manufactures biological scaffolds & other medical equipment | Corporate Officer/Principal | - |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Synairgen Plc
 Synairgen Plc Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for respiratory disorders | Health Technology |
RioTech Pharmaceuticals Ltd.
 RioTech Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutic drugs for hepatitis C virus | Health Technology |
Cytomyx Holdings Plc
 Cytomyx Holdings Plc Pharmaceuticals: MajorHealth Technology Provides drug discovery products and services | Health Technology |
OrthoMimetics Ltd.
OrthoMimetics Ltd. Medical SpecialtiesHealth Technology Designs, develops and manufactures biological scaffolds & other medical equipment | Health Technology |
Hybrid BioSystems Ltd.
 Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy treatments for ovarian and prostate cancer | Commercial Services |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Commercial Services |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Health Technology |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Health Technology |
